When both premenopausal and menopausal women were considered together, CST IV was less prevalent in SGLT2 inhibitor users (H and I) than in non-users (J and K), although this difference did not reach statistical significance ( p = 0.079, Fisher’s exact test).
← all excerpts
The Clinically Significant Changes in the Composition and Functional Diversity of the Vaginal Microbiome in Women with Type 2 Diabetes Mellitus.
1
0.0790
0.0790